Anna Barry, Ph.D., J.D., chief operating officer at Korro Bio, is a seasoned biotech executive with more than 20 years of senior leadership and legal experience in the life sciences industry. Prior to Korro, Anna was most recently senior vice president, general counsel and corporate secretary at Jounce Therapeutics, where she was responsible for all aspects of its legal department, negotiated strategic partnerships and executed its initial public offering.
Prior to Jounce Therapeutics, Anna served as a senior director of IP at Five Prime Therapeutics and senior patent counsel at Genentech. Prior to Genentech, Anna was an attorney at Heller Ehrman LLP, where her practice focused on counseling life sciences and biotechnology companies.
Anna received her J.D. from Vanderbilt University, an M.S. and a Ph.D. in biophysical chemistry from Yale University and a B.S. in chemistry from Georgia Institute of Technology.